Sunrest Lifescience Limited (NSE:SUNREST)
33.00
+2.50 (8.20%)
Jan 23, 2026, 1:05 PM IST
Sunrest Lifescience Revenue
Sunrest Lifescience had revenue of 340.11M INR in the half year ending September 30, 2025, with 172.63% growth. This brings the company's revenue in the last twelve months to 520.34M, up 60.61% year-over-year. In the fiscal year ending March 31, 2025, Sunrest Lifescience had annual revenue of 334.13M with 13.33% growth.
Revenue (ttm)
520.34M
Revenue Growth
+60.61%
P/S Ratio
0.27
Revenue / Employee
2.48M
Employees
210
Market Cap
141.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 334.13M | 39.30M | 13.33% |
| Mar 31, 2024 | 294.83M | 48.41M | 19.64% |
| Mar 31, 2023 | 246.42M | -22.46M | -8.35% |
| Mar 31, 2022 | 268.88M | 99.38M | 58.64% |
| Mar 31, 2021 | 169.49M | 59.97M | 54.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cian Healthcare | 232.80M |
| Beryl Drugs | 191.97M |
| Unjha Formulations | 141.50M |
| Zenith Healthcare | 112.08M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.72M |